Agreement covers protein-alkylating, tumour-activated pro-drug payload series for ADC development

Data demonstrated a 90% successful lumbar vertebrae fusion rate at 24 months

Updated Date: Tue, 06 Oct 2020 00:00:00 EDT

Updated Date: Tue, 06 Oct 2020 00:00:00 EDT

Updated Date: Tue, 06 Oct 2020 00:00:00 EDT

Updated Date: Tue, 06 Oct 2020 00:00:00 EDT

Updated Date: Tue, 06 Oct 2020 00:00:00 EDT

Ear wax resistant to home treatment is a common problem. Treatment has been provided by many, if not […]

Doshi discusses the studies that have shown pre-existing immunity to SARS-CoV-2.[3] Most governments have based their decisions in […]

Takeda-led alliance starts scaling up production of COVID-19 plasma therapy as phase 3 kicks off: report aliu Tue, […]